Canada Approves Biogen Idec's Long-Acting Alprolix™ for Hemophilia B

The Approval of ALPROLIX is First Significant Advance in Hemophilia B Treatment in More Than 17 YearsToday Biogen Idec announced that Health Canada has approved ALPROLIX™ [Coagulation Factor IX (Recombinant), Fc Fusion Protein], for the control and prevention of bleeding episodes and routine prophylaxis in adults, and children aged 12 and older, with hemophilia B. ALPROLIX […]

1990s-A Time for Action

NHF Congressional Update volume 2, number 1February 1995 Introduction Set For Late February! THE RICKY RAY HEMOPHILIA RELIEF FUND ACT OF 1995 This month marks a new beginning for our community… the Ricky Ray Hemophilia Relief Fund Act of 1995 is being introduced. This is a victory for us all and is happening because of the […]